AVBP
ArriVent BioPharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$28.90
+1.90%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-44.6%
Return on equity
-41.5%
Return on assets
-47.9%
Return on invested capital
0.00x
Asset turnover
-$147.9M
Cash from operations
$7.57
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026